The University of Chicago Header Logo

Connection

Milica Medved to Neoadjuvant Therapy

Back to Details
This is a "connection" page, showing publications Milica Medved has written about Neoadjuvant Therapy.
Milica Medved
Connection Strength
0.040
Neoadjuvant Therapy
  1. Differences Between Ipsilateral and Contralateral Early Parenchymal Enhancement Kinetics Predict Response of Breast Cancer to Neoadjuvant Therapy. Acad Radiol. 2022 10; 29(10):1469-1479.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.